Navigation Links
Despite Decline in Share of Global Output, U.S. Science Impact Still Strong, Says Thomson Reuters
Date:1/28/2009

PHILADELPHIA and LONDON, Jan. 28 /PRNewswire/ -- The Scientific business of Thomson Reuters today announced the results of a study showing that the United States' share of scientific research output continues to shrink while Asia-Pacific's share of output rises. Nevertheless, the U.S. retains a healthy footing globally in the relative impact of its research.

In its January/February issue of Science Watch, Thomson Reuters analyzes 12 year's worth of data from its National Science Indicators database to determine the U.S.'s global scientific influence based on the nation's research output and impact.

In 2005, Science Watch noted that the U.S.'s output, as a percentage of world science, was in decline, with Asia-Pacific's output steadily rising. This latest analysis shows the trends continuing. In 2005, the U.S. contributed 32.8 percent of global research; by 2007 its share slid to 31.5 percent. During the same period, Asia-Pacific's share increased from 25.9 percent to 28.2 percent.

"It is important to note that measuring scientific output is only one way to measure a country's influence in the sciences," said Christopher King, editor of Science Watch. "Because citations are an acknowledgement of intellectual debt, we also evaluate a country's citation impact. The U.S.'s citation impact has remained strong in the major science fields."

In all 21 science fields analyzed for this report, the U.S. markedly surpassed the world average in citation impact. Topping the list was Physics, where the U.S. exceeded the world mark by 55 percent, followed by Chemistry and Materials Science where the U.S. exceeded the world by 52 percent and 47 percent, respectively.

For more information about U.S. research output and impact, including expert analysis, visit ScienceWatch.com.

About Thomson Reuters

Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, scientific, healthcare and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 50,000 people in 93 countries. For more information, go to www.thomsonreuters.com.


'/>"/>
SOURCE Thomson Reuters
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Fadel Partners Announces 13% Growth Despite IT Services Industry Downtrend
2. Despite Economic Woes, Physician Compensation Increases
3. Investment and Growth in US Medical Technology Industry Continues Despite Challenging Public Markets
4. Multigene Test Predicts Who Could Avoid Chemotherapy Despite Positive Lymph Nodes in Early Breast Cancer
5. Cell Therapeutics Net Loss Declines as Operating Expenses Decrease By 58% in Third Quarter 2008
6. Data show a decline in cystic fibrosis since introduction of prenatal carrier screening
7. Entry of Biogenerics and Decreasing Use of Amgens Epogen and Johnson & Johnsons Procrit Will Cause a $2.8 Billion Decline in the Drug Market for Chemotherapy-Induced Anemia by 2016
8. Progen Shareholders Call Meeting to Spill Progen Board and Offer Merger or Full Cash Back to Shareholders
9. Amgens Fourth Quarter 2008 Adjusted Earnings Per Share Increased 6 Percent to $1.06; Full Year 2008 Adjusted Earnings Per Share Increased 6 Percent to $4.55
10. IntraLinks Poll: Half of Clinical Trial Management Professionals Share Critical Information Via E-Mail
11. Cell Therapeutics, Inc. Provides Update on the Special Meeting of Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 27, 2016 , ... Parallel 6 , the leading software as a ... Reach Virtual Patient Encounter CONSULT module which enables both audio and video telemedicine ... team. , Using the CONSULT module, patients and physicians can schedule a face to ...
(Date:6/27/2016)... -- Liquid Biotech USA , Inc. ... Research Agreement with The University of Pennsylvania ("PENN") ... patients.  The funding will be used to assess ... outcomes in cancer patients undergoing a variety of ... to support the design of a therapeutic, decision-making ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader in ... Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio ... practical tips, tools, and strategies for clinical researchers. , “The landscape of how ...
Breaking Biology Technology:
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a provider ... MegaMatcher Automated Biometric Identification System (ABIS) , ... multi-biometric projects. MegaMatcher ABIS can process multiple complex ... any combination of fingerprint, face or iris biometrics. ... SDK and MegaMatcher Accelerator , which ...
(Date:4/19/2016)... -- The new GEZE SecuLogic access control ... system solution for all door components. It can be ... interface with integration authorization management system, and thus fulfills ... dimensions of the access control and the optimum integration ... considerable freedom of design with regard to the doors. ...
(Date:3/31/2016)... , March 31, 2016   ... ("LegacyXChange" or the "Company") LegacyXChange is excited ... of its soon to be launched online site for ... https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide potential shareholders a ... DNA technology to an industry that is notorious for ...
Breaking Biology News(10 mins):